Related content

“How to increase return on investment of the intensive care pharmacist—fear of flying”: answer to Dr. Patel et al.

By Hartmann Michael   Meier-Hellmann Andreas  

Intensive Care Medicine, Vol. 32, Iss. 8, 2006-08 ,pp. : 1277-1277

Springer Publishing Company

Access to resources Recommend Favorite

How many intensive care beds are enough?

By Rubenfeld Gordon   Rhodes Andrew  

Intensive Care Medicine, Vol. 40, Iss. 3, 2014-03 ,pp. : 451-452

Springer Publishing Company

Access to resources Recommend Favorite

Impact of pharmacist antimicrobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit

By Jiang Sai-Ping   Zhu Zheng-Yi   Ma Kui-Fen   Zheng Xia   Lu Xiao-Yang  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 12, 2013-12 ,pp. : 891-899

Informa Healthcare

Access to resources Recommend Favorite

How physician and community pharmacist perceptions of the community pharmacist role in Australian primary care influence the quality of collaborative chronic disease management

By Rieck Allison  

Quality in Primary Care, Vol. 21, Iss. 2, 2013-05 ,pp. : 105-111

Radcliffe Press

Access to resources Recommend Favorite

Pets or meds: how to tackle misery in a paediatric intensive care unit

By Vos Gijs   Os Jim   Leroy Piet   Schieveld Jan  

Intensive Care Medicine, Vol. 33, Iss. 8, 2007-08 ,pp. : 1492-1493

Springer Publishing Company

Access to resources Recommend Favorite